Ortho vision reagents and consumables

Ended Indefinite Delivery Contract Awarded Last action

Contract number
W81K0220D0008
Awardee
Awarding agency
Task orders
5 $997,323 obligated

Award facts

Opportunity
Combined order value
$997,323 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 38% used
$2,655,406.12
Maximum order
$596,819.77
Award type
Single award
Who can order
Only the awarding agency
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
1 offer Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a single-award indefinite delivery contract by the Defense Health Agency on June 1, 2020, with a ceiling value of $2,655,406.12 and ultimate completion date of September 30, 2024. The contract procures Ortho Vision reagents and consumables to support diagnostic laboratory operations at military treatment facilities, with performance locations primarily in Raritan, New Jersey and South Korea. No set-aside designation was utilized in this competitive procurement. The contractor, a self-certified HUBZone joint venture and for-profit medical equipment manufacturer, provided specialized laboratory testing supplies and reagent products essential to blood bank analyzer operations and clinical laboratory diagnostics throughout the contract period.

Five firm fixed-price delivery orders were issued under this indefinite delivery vehicle spanning fiscal years 2020 through 2024, with individual ceiling values ranging from $42,832.25 to $317,651.53. The initial minimum requirements delivery order was awarded June 1, 2020, for $42,832.25, followed by Option I (October 1, 2020 – September 30, 2021) valued at $317,651.53, fiscal year 2022 delivery order (October 1, 2021 – September 30, 2022) valued at $287,503.91, fiscal year 2023 delivery order (October 1, 2022 – September 30, 2023) valued at $204,015.95, and Option IV (October 1, 2023 – September 30, 2024) valued at $145,319.06 for South Korea performance. These delivery orders collectively demonstrate sustained federal demand for the contractor's Ortho Vision analyzer reagents and associated consumables to maintain critical laboratory diagnostic capabilities across Defense Health Agency and Medical Command treatment facilities.

Task orders

Task order Ordering agency Obligated Awarded
Ortho vision reagents and consumables - delivery order for option period IV: 1 OCT 2023 - 30 SEP 2024 W81K0223F0128 Medical Command (Army) $145,319
Ortho vision reagents and consumables do for FY23 10/1/2022-09/30/2023 W81K0222F0097 Medical Command (Army) $204,016
Ortho vision reagents and consumables do for FY22 10/1/2021-09/30/22 W81K0221F0152 Medical Command (Army) $287,504
Ortho vision reagents and consumables exercise option i 10/01/2020-0/30/2021 W81K0220F0224 Medical Command (Army) $317,652
Ortho vision reagents and consumables minimum requirement W81K0220F0170 Medical Command (Army) $42,832

Transactions

Action Obligated Date
Exercise an Option P00009 · Ortho vision reagents and consumables MOD P9 exercise option IV 10/1/23 - 9/30/24 for bdaach korea $0
Supplemental Agreement for work within scope P00008 · Ortho vision reagents and consumables - add 52.204-27 prohibition on bytedance covered application $0
Other Administrative Action P00007 · Ortho vision reagents and consumables aadmin MOD to restructure clins for UOM "job" $0
Exercise an Option P00006 · Ortho vision reagents and consumables MOD P6 exercise option III 10/01/2022-09/30/2023 $0
Supplemental Agreement for work within scope P00005 · Ortho vision reagents and consumables MOD P00005 incorporate dfars 252.211-70003 $0
Exercise an Option P00004 · Ortho vision reagents and consumables MOD P00004, EX option II 10/1/2021-9/30/2022 $0
Supplemental Agreement for work within scope P00003 · Ortho vision reagents and consumables MOD P00003, change maximum quantity $0
Supplemental Agreement for work within scope P00002 · 889 action - ortho vision reagents and consumables $0
Exercise an Option P00001 · Ortho vision reagents and consumables MOD P00001 to exercise option i 10/01/2020-9/30/2021 $0
Original award $0

Quick answers

Who was awarded contract W81K0220D0008?

W81K0220D0008 was awarded to Ortho-Clinical Diagnostics, Inc. by Medical Command (Department of the Army) on June 1, 2020.

How much is contract W81K0220D0008 worth?

Orders under W81K0220D0008 have obligated $997,323. W81K0220D0008's own ceiling is $2,655,406. A single order can be worth up to $596,820.

How many orders have been placed under contract W81K0220D0008?

5 orders have been placed under W81K0220D0008, the latest on October 1, 2023.

Which agency awarded contract W81K0220D0008?

Medical Command (Department of the Army) awarded W81K0220D0008, with funding from Defense Health Agency (Department of Defense).

Who can order from contract W81K0220D0008?

W81K0220D0008 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0220D0008 competed?

The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login